Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NBP608 vs Zostavax for Herpes Zoster Prevention
NCT03116594Phase 3Completed
- Sponsor
- SK Chemicals
- Start
- Jan 2014
- Primary completion
- Apr 2014
- Modality
- Live Attenuated Vaccines
- Countries
- 1
01
Overview
A Phase 3 trial of NBP608 in herpes zoster (HZ), sponsored by SK Chemicals. Started Jan 2014; status: completed.
02
Drugs
NBP608
03
Conditions
herpes zoster (HZ)
Beyond the preview
Go deeper on NCT03116594.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03116594.